Clinical Trial Update: Controlled, 12-Week Study of Albuterol HFA Versus the Active Control, Proventil(R)-HFA in Asthmatic Patients [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing Albuterol HFA to Proventil-HFA in asthmatic patients was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Albuterol-HFA (albuterol)
• Proventil-HFA (albuterol)

Snippet

Sponsor: Amphastar Pharmaceuticals, Inc. | Conditions: Asthma | Phase 3 | Status: TERMINATED